% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Wellach:301580,
author = {K. Wellach$^*$ and A. Riemer$^*$},
title = {{H}ighly sensitive live-cell imaging-based cytotoxicity
assay enables functional validation of rare epitope-specific
{CTL}s.},
journal = {Frontiers in immunology},
volume = {16},
issn = {1664-3224},
address = {Lausanne},
publisher = {Frontiers Media},
reportid = {DKFZ-2025-01088},
pages = {1558620},
year = {2025},
note = {#EA:D410#LA:D410#},
abstract = {Many immunotherapeutic approaches aim to induce
epitope-specific T-cell cytotoxicity. However, the
identification-and especially the functional validation-of
suitable epitopes by in vitro cytotoxicity assays can be
challenging, particularly when the number of available
epitope-specific cytotoxic T cells (CTLs) is limited. Here,
we present a highly sensitive image-based cytotoxicity assay
that allows the functional analysis of rare epitope-specific
T cells. The live-cell imaging-based setup combines
transient red labeling of target cells with a green caspase
3/7 probe, allowing reliable measurement of the fraction of
apoptotic target cells. Time-course analysis enables the
monitoring of subtle differences. This highly flexible assay
can be applied to assess the killing of either target cells
with endogenous epitope presentation or those artificially
loaded with the epitope of interest. Analysis of assay
sensitivity demonstrated that cytotoxicity mediated by as
few as $0.1\%$ epitope-specific CTLs in a T-cell culture can
still be detected. The epitope-specificity of the assay was
additionally validated by specific upregulation of PD-1 and
LAG-3 on epitope-specific T cells, as well as the
epitope-specific induction of interferon-γ release.
Finally, the assay was successfully applied to functionally
validate human papillomavirus (HPV)16 epitopes, by detecting
epitope-specific killing of established patient-derived
tumor cell lines by rare T-cell populations expanded from
peripheral blood. Overall, this cytotoxicity assay setup
provides a straightforward approach to assess the cytotoxic
capacity of rare epitope-specific T cells and enables the
analysis of T-cell responses against endogenously presented
epitopes.},
keywords = {Humans / T-Lymphocytes, Cytotoxic: immunology /
T-Lymphocytes, Cytotoxic: metabolism / Epitopes,
T-Lymphocyte: immunology / Cytotoxicity, Immunologic /
Lymphocyte Activation Gene 3 Protein / Cytotoxicity Tests,
Immunologic: methods / Cell Line, Tumor / Interferon-gamma:
metabolism / Programmed Cell Death 1 Receptor: metabolism /
Programmed Cell Death 1 Receptor: immunology / Apoptosis /
Caspase 3: metabolism / T cells (Other) / cytotoxicity
(Other) / epitopes (Other) / live-cell imaging (Other) /
rare CTL populations (Other) / Epitopes, T-Lymphocyte (NLM
Chemicals) / Lymphocyte Activation Gene 3 Protein (NLM
Chemicals) / Interferon-gamma (NLM Chemicals) / Lag3
protein, human (NLM Chemicals) / Programmed Cell Death 1
Receptor (NLM Chemicals) / Caspase 3 (NLM Chemicals)},
cin = {D410},
ddc = {610},
cid = {I:(DE-He78)D410-20160331},
pnm = {314 - Immunologie und Krebs (POF4-314)},
pid = {G:(DE-HGF)POF4-314},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:40406125},
pmc = {pmc:PMC12095279},
doi = {10.3389/fimmu.2025.1558620},
url = {https://inrepo02.dkfz.de/record/301580},
}